These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3477663

  • 1. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
    Frankfurt OS.
    J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
    [Abstract] [Full Text] [Related]

  • 2. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R, Reiter W, Krishan A.
    J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N, Ramu A, Cole DE, Balis FM, Poplack DG, Pollard HB.
    Isr J Med Sci; 1988 Jun; 24(9-10):477-82. PubMed ID: 2974448
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
    Ganapathi R, Grabowski D, Rouse W, Riegler F.
    Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
    [Abstract] [Full Text] [Related]

  • 5. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
    Nair S, Horton A, Leif RC, Krishan A.
    Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
    [Abstract] [Full Text] [Related]

  • 6. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting.
    Ross DD, Ordóñez JV, Joneckis CC, Testa JR, Thompson BW.
    Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281
    [Abstract] [Full Text] [Related]

  • 7. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
    Yin MB, Bankusli I, Frank C, Rustum YM.
    Anticancer Res; 1990 Jul; 10(2A):327-32. PubMed ID: 2346306
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN, Pierson NR.
    Cancer Res; 1990 Feb 15; 50(4):1165-9. PubMed ID: 2297765
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug 15; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

  • 10. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ, Wang H, Blair GW.
    Cancer Res; 1986 Jun 15; 46(6):2978-83. PubMed ID: 3698020
    [Abstract] [Full Text] [Related]

  • 11. Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content.
    Ross DD, Thompson BW, Ordóñez JV, Joneckis CC.
    Cytometry; 1989 Mar 15; 10(2):185-91. PubMed ID: 2714107
    [Abstract] [Full Text] [Related]

  • 12. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
    Ramu A, Glaubiger D, Magrath IT, Joshi A.
    Cancer Res; 1983 Nov 15; 43(11):5533-7. PubMed ID: 6311408
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S, Fujimura T, Kawauchi H, Sasaki K, Takayanagi Y.
    Res Commun Chem Pathol Pharmacol; 1991 Mar 15; 71(3):321-36. PubMed ID: 2047575
    [Abstract] [Full Text] [Related]

  • 14. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
    Chan PK, Aldrich MB, Yung BY.
    Cancer Res; 1987 Jul 15; 47(14):3798-801. PubMed ID: 2439199
    [Abstract] [Full Text] [Related]

  • 15. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
    Moroz LV, Donenko FV, Borovkova NB, Sitdikova SM.
    Biull Eksp Biol Med; 1989 Dec 15; 108(12):714-6. PubMed ID: 2634447
    [Abstract] [Full Text] [Related]

  • 16. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A, Cohen L, Glaubiger D.
    Cancer Res; 1984 May 15; 44(5):1976-80. PubMed ID: 6324993
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
    Krishan A, Sauerteig A, Gordon K, Swinkin C.
    Cancer Res; 1986 Apr 15; 46(4 Pt 1):1768-73. PubMed ID: 3948163
    [Abstract] [Full Text] [Related]

  • 18. In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
    Ling YH, Priebe W, Yang LY, Burke TG, Pommier Y, Perez-Soler R.
    Cancer Res; 1993 Apr 01; 53(7):1583-9. PubMed ID: 8453627
    [Abstract] [Full Text] [Related]

  • 19. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA, Demidova NS, Shiriaeva OA, Shevtsova VN, Konovalova NP.
    Eksp Onkol; 1987 Apr 01; 9(4):42-7. PubMed ID: 3678124
    [Abstract] [Full Text] [Related]

  • 20. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E, Menconi E, Barzi AM.
    Boll Soc Ital Biol Sper; 1984 Jul 31; 60(7):1369-75. PubMed ID: 6477749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.